ArticleTranslational animal science2026
Effects of direct-fed microbial supplementation on feedlot lamb growth performance, serum biochemical markers, fecal consistency, and fecal microbiota.
Article in Translational animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dietary, environmental, and physiological changes can challenge lamb health and performance during the feedlot transition. This study evaluated supplementation with a liquid direct-fed microbial (DFM; RSG Prime by BIO S.I.) on growth, fecal consistency, blood parameters, and fecal microbial populations in feedlot lambs fed a high-concentrate diet. Seventy-two Dorper × Katahdin lambs (60 d of age, initially 26.73 ± 0.35 kg BW) were fed for 63 d at Kansas State University. Lambs were randomly assigned by initial body weight to pens (3 lambs/pen) and allotted to one of two treatments during the treatment period (d 0-63), with 12 replications per treatment. Treatments were (1) control (CON, no DFM) or (2) DFM supplementation (15 mL/head, orally once daily at 08:00). The DFM contained
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.